Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GLYCOPROTEIN-IIB/IIIA RECEPTOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 70 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Clutton, P; Folts, JD; Freedman, JE
      Pharmacological control of platelet function

      PHARMACOLOGICAL RESEARCH
    2. Easton, JD
      Future perspectives for optimizing oral antiplatelet therapy

      CEREBROVASCULAR DISEASES
    3. Smith, BS; Gandhi, PJ
      Pharmacokinetics and pharmacodynamics of low-molecular-weight heparins andglycoprotein IIb/IIIa receptor antagonists in renal failure

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    4. Lin, PH; Bush, RL; Tong, FC; Chaikof, E; Martin, LG; Lumsden, AB
      Intra-arterial thrombin injection of an ascending aortic pseudoaneurysm complicated by transient ischemic attack and rescued with systemic abciximab

      JOURNAL OF VASCULAR SURGERY
    5. Sassoli, PM; Emmell, EL; Tam, SH; Trikha, M; Zhou, Z; Jordan, RE; Nakada, MT
      7E3 F(ab ')(2), an effective antagonist of rat alpha IIb beta 3 and alpha v beta 3, blocks in vivo thrombus formation and in vitro angiogenesis

      THROMBOSIS AND HAEMOSTASIS
    6. Zwart-van Rijkom, JEF; Klungel, OH; Leufkens, HGM; Broekmans, AW; Schrijver-van Velthoven, S; Umans, VA
      Costs and effects of combining stenting and abciximab (ReoPro (R)) in daily practice

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    7. Truong, KM; Amankwa, K; Kucukarslan, S
      Platelet glycoprotein IIb/IIIa-receptor inhibitors in patients with acute coronary syndromes or undergoing percutaneous coronary interventions: A review

      CLINICAL THERAPEUTICS
    8. Verheugt, FWA
      GP IIB/IIIA blockers with and without thrombolytic agent in prehospital treatment of acute myocardial infarction

      THROMBOSIS RESEARCH
    9. Kageyama, S; Yamamoto, H; Nakazawa, H; Yoshimoto, R
      Anti-human vWF monoclonal antibody, AJvW-2 fab, inhibits repetitive coronary artery thrombosis without bleeding time prolongation in dogs

      THROMBOSIS RESEARCH
    10. Yang, Y; Li, Q; Nakada, MT; Yang, T; Shuaib, A
      Angiographic evaluation of middle cerebral artery reperfusion caused by platelet glycoprotein IIb/IIIa receptor complex antagonist murine 7E3 F(ab ')(2) in a model of focal cerebral ischemia in rats

      JOURNAL OF NEUROSURGERY
    11. Rosado, JA; Meijer, EMY; Hamulyak, K; Novakova, I; Heemskerk, JWM; Sage, SO
      Fibrinogen binding to the integrin alpha(IIb)beta(3) modulates store-mediated calcium entry in human platelets

      BLOOD
    12. Schneiderman, J; Morag, B; Gerniak, A; Rimon, U; Varon, D; Seligsohn, U; Shotan, A; Adar, R
      Abciximab in carotid stenting for postsurgical carotid restenosis: Intermediate results

      JOURNAL OF ENDOVASCULAR THERAPY
    13. Liu, FQ; Craft, RM; Morris, SA; Carroll, RC
      Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    14. Frangos, SG; Chen, AH; Sumpio, B
      Vascular drugs in the new millennium

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    15. Koestenberger, M; Gallistl, S; Cvirn, G; Roschitz, B; Muntean, W
      Effects of the glycoprotein IIb/IIIa receptor antagonist c7E3 Fab and anticoagulants on platelet aggregation and thrombin potential under high coagulant challenge in vitro

      BLOOD COAGULATION & FIBRINOLYSIS
    16. Li, YF; Spencer, FA; Ball, S; Becker, RC
      Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: Potential contributing mechanism of benefit in acute coronary syndromes

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    17. Talley, JD
      Pharmacology of GP IIb-IIIa platelet inhibitors, part IV

      JOURNAL OF INTERVENTIONAL CARDIOLOGY
    18. Peter, K; Nordt, T; Bode, C
      Therapeutic inhibition of platelets in acute coronary syndrome and in coronary intervention: mechanisms and clinical results

      ZEITSCHRIFT FUR KARDIOLOGIE
    19. Akkerhuis, KM; Deckers, JW; Boersma, E; Harrington, RA; Stepinska, J; Mahaffey, KW; Wilcox, RG; Lincoff, AM; Keltai, M; Topol, EJ; Califf, RM; Simoons, ML
      Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes - Results from PURSUIT

      EUROPEAN HEART JOURNAL
    20. Cannon, CP
      Learning from the recently completed oral glycoprotein IIb/IIIa receptor antagonist trials

      CLINICAL CARDIOLOGY
    21. Topol, EJ
      The future of antiplatelet therapy: Optimizing management in patients withacute coronary syndrome

      CLINICAL CARDIOLOGY
    22. Yomo, T; Serna, DL; Powell, LL; Wang, D; Wilson, SE; Ishimaru, S; Chen, JC
      Glycoprotein IIb/IIIa receptor inhibitor attenuates platelet aggregation induced by thromboxane A2 during in vitro nonpulsatile ventricular assist circulation

      ARTIFICIAL ORGANS
    23. Mousa, SA
      Comparative efficacy of different low-molecular-weight heparins (LMWHs) and drug interactions with LMWH: Implications for management of vascular disorders

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    24. Brodison, A; Katira, R; More, RS; Chauhan, A
      Antiplatelet use in interventional cardiology

      POSTGRADUATE MEDICAL JOURNAL
    25. Katoh, M; Karasawa, T; Doi, H; Odawara, A; Takagi, M; Ikeo, T; Narita, H
      Antiplatelet mechanisms of TA-993 and its metabolite MB3 in ADP-induced platelet aggregation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    26. Kaushansky, K
      Blood: New designs for a new millennium

      BLOOD
    27. Harrington, RA
      The PURSUIT results in perspective

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    28. Jordan, R; Mascelli, MA
      Pharmacological differentiation of GP IIb/IIIa inhibitors

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    29. Lincoff, AM; Korngold, S
      An overview of platelet GP IIb/IIIa receptor antagonists trials

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    30. Kleiman, NS; Tcheng, JE
      Safety issues surrounding use of platelet GP IIb/IIIa antagonists: reversibility and readministration

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    31. Hermiller, J; Kereiakes, DJ
      Economic considerations in the use of the platelet GP IIb/IIIa inhibitor abciximab in percutaneous coronary intervention

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    32. Robinson, N; Barakat, K; Dymond, D
      Platelet IIb/IIIa antagonists followed by delayed stent implantation. A new treatment for vein graft lesions containing massive thrombus

      HEART
    33. Mousa, SA; Kapil, R; Mu, DX
      Intravenous and oral antithrombotic efficacy of the novel platelet GPIIb/IIIa antagonist roxifiban (DMP754) and its free acid form, XV459

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    34. Amidon, TM; Amidon, JB; Benson, JM; Coffler, D
      Tirofiban and intracoronary stenting: Evaluation of a new pharmacologic regimen

      JOURNAL OF INVASIVE CARDIOLOGY
    35. Taillefer, R; Therasse, E; Turpin, S; Lambert, R; Robillard, P; Soulez, G
      Comparison of early and delayed scintigraphy with Tc-99m-apcitide and correlation with contrast-enhanced venography in detection of acute deep vein thrombosis

      JOURNAL OF NUCLEAR MEDICINE
    36. Hu, DD; White, CA; Panzer-Knodle, S; Page, JD; Nicholson, N; Smith, JW
      A new model of dual interacting ligand binding sites on integrin alpha(IIb)beta(3)

      JOURNAL OF BIOLOGICAL CHEMISTRY
    37. Banno, H; Kawazura, H; Yutaka, T; Sakuma, N; Kitamori, T; Hosoya, J; Kibayashi, K; Yamashita, H; Umemura, K; Nakashima, M
      Antiaggregatory, antithrombotic effects of MS-180, a novel platelet glycoprotein IIb/IIIa receptor antagonist

      EUROPEAN JOURNAL OF PHARMACOLOGY
    38. Goa, KL; Noble, S
      Eptifibatide - A review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention

      DRUGS
    39. Hooper, WC; Lally, C; Austin, H; Benson, J; Dilley, A; Wenger, NK; Whitsett, C; Rawlins, P; Evatt, BL
      The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction andvenous thromboembolism in African Americans

      CHEST
    40. Burkhard-Meier, S; Deutsch, HJ; Erdmann, E
      Current management of unstable angina

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    41. MEYER BJ
      ANTITHROMBOTIC DRUGS - INSIGHTS FROM CARDIOLOGY

      Cerebrovascular diseases
    42. Kleiman, NS
      Pharmacology of the intravenous platelet receptor glycoprotein IIb-IIIa antagonists

      CORONARY ARTERY DISEASE
    43. GIUGLIANO RP
      DRUG-INDUCED THROMBOCYTOPENIA - IS IT A SERIOUS CONCERN FOR GLYCOPROTEIN IIB IIIA RECEPTOR INHIBITORS/

      Journal of thrombosis and thrombolysis
    44. HAMM CW
      PROGRESS IN THE DIAGNOSIS OF UNSTABLE ANGINA AND PERSPECTIVES FOR TREATMENT

      European heart journal
    45. DOMANOVITS H; NIKFARDJAM M; JANATA K; HORNYKEWYCZ S; MAURER G; LAGGNER AN; HUBER K
      RESTORATION OF CORONARY BLOOD-FLOW BY SINGLE BOLUS INJECTION OF THE GPIIB IIIA RECEPTOR ANTAGONIST C7E3 FAB IN A PATIENT WITH ACUTE MYOCARDIAL-INFARCTION OF RECENT-ONSET/

      Clinical cardiology
    46. MOUSA SA; FORSYTHE M; BOZARTH J; YOUSSEF A; WITYAK J; OLSON R; SIELECKI T
      XV454, A NOVEL NONPEPTIDE SMALL-MOLECULE PLATELET GIIB IIIA ANTAGONIST WITH COMPARABLE PLATELET ALPHA(IIB)BETA(3)-BINDING KINETICS TO C7E3/

      Journal of cardiovascular pharmacology
    47. MOUSA SA; OLSON RE; BOZARTH JM; LORELLI W; FORSYTHE MS; RACANELLI A; GIBBS S; SCHLINGMAN K; BOZARTH T; KAPIL R; WITYAK J; SIELECKI TM; WEXLER RR; THOOLEN MJ; SLEE A; REILLY TM; ANDERSON PS; FRIEDMAN PA
      ORAL ANTIPLATELET EFFICACY AND SPECIFICITY OF A NOVEL NONPEPTIDE PLATELET GPIIB IIIA RECEPTOR ANTAGONIST, DMP-802/

      Journal of cardiovascular pharmacology
    48. MOUSA SA; FORSYTHE M; WITYAK J; BOZARTH J; MU DX
      INTRAVENOUS AND ORAL ANTIPLATELET ANTITHROMBOTIC EFFICACY AND SPECIFICITY OF XR300, A NOVEL NONPEPTIDE PLATELET GPIIB/IIIA ANTAGONIST/

      Journal of cardiovascular pharmacology
    49. ALTON KB; KOSOGLOU T; BAKER S; AFFRIME MB; CAYEN MN; PATRICK JE
      DISPOSITION OF C-14-EPTIFIBATIDE AFTER INTRAVENOUS ADMINISTRATION TO HEALTHY-MEN

      Clinical therapeutics
    50. MOUSA SA; MU DX; HUSSAIN MA
      INTRANASAL ANTIPLATELET ANTITHROMBOTIC EFFICACY OF A NOVEL PLATELET GPIIB/IIIA RECEPTOR ANTAGONIST DMP755/

      Thrombosis research
    51. HERMAN AG
      RATIONALE FOR THE COMBINATION OF ANTI-AGGREGATING DRUGS

      Thrombosis research
    52. HANTGAN RR; MOUSA SA
      INHIBITION OF PLATELET-MEDIATED CLOT RETRACTION BY INTEGRIN ANTAGONISTS

      Thrombosis research
    53. MOUSA SA; BOZARTH J; YOUSSEF A; LEVINE B
      ORAL ANTIPLATELET EFFICACY OF THE PLATELET GPIIB IIIA ANTAGONIST, DMP754 IN NONHUMAN-PRIMATES/

      Thrombosis research
    54. MOUSA SA; BOZARTH JM; LORELLI W; FORSYTHE MS; THOOLEN MJMC; SLEE AM; REILLY TM; FRIEDMAN PA
      ANTIPLATELET EFFICACY OF XV459, A NOVEL NONPEPTIDE PLATELET GPIIB IIAANTAGONIST - COMPARATIVE PLATELET BINDING PROFILES WITH C7E3/

      The Journal of pharmacology and experimental therapeutics
    55. WHITE HD; FRENCH JK; ELLIS CJ
      NEW ANTIPLATELET AGENTS

      Australian and New Zealand Journal of Medicine
    56. COLLER BS
      PLATELET GPIIB IIIA ANTAGONISTS - THE FIRST ANTI-INTEGRIN RECEPTOR THERAPEUTICS/

      The Journal of clinical investigation
    57. COLLER BS
      PLATELET GPIIB IIIA ANTAGONISTS - THE FIRST ANTI-INTEGRIN RECEPTOR THERAPEUTICS/

      The Journal of clinical investigation
    58. ARONEY CN
      IMPROVING THE RESULTS OF CORONARY ANGIOPLASTY

      Australian and New Zealand Journal of Medicine
    59. WEISMAN HF; SCHAIBLE TF; JORDAN RE; CABOT CF; ANDERSON KM
      ANTIPLATETLET MONOCLONAL-ANTIBODIES FOR THE PREVENTION OF ARTERIAL THROMBOSIS - EXPERIENCE WITH REOPRO, A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GPIIB IIIA RECEPTOR/

      Biochemical Society transactions
    60. COLLER BS
      THE ROLE OF PLATELETS IN ARTERIAL THROMBOSIS AND THE RATIONALE FOR BLOCKADE OF PLATELET GPIIB IIIA RECEPTORS AS ANTITHROMBOTIC THERAPY/

      European heart journal
    61. COLLER BS
      BLOCKADE OF PLATELET GPIIB IIIA RECEPTORS AS AN ANTITHROMBOTIC STRATEGY/

      Circulation
    62. WILSON JM; FERGUSON JJ
      THE THERAPEUTIC POTENTIAL OF ABCIRXIMAB (C7E3-FAB) IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - IMPLICATIONS OF THE EPIC STUDY

      CLINICAL IMMUNOTHERAPEUTICS
    63. KISS RG; LU HR; ROSKAMS T; JANG IK; PLOW EF; GOLD HK; COLLEN D
      TIME-COURSE OF THE EFFECTS OF A SINGLE BOLUS INJECTION OF F(AB')(2) FRAGMENTS OF THE ANTIPLATELET GPIIB IIIA ANTIBODY 7E3 ON ARTERIAL EVERSION GRAFT OCCLUSION, PLATELET-AGGREGATION, AND BLEEDING-TIME IN DOGS/

      Arteriosclerosis and thrombosis
    64. COLLEN D; LU HR; STASSEN JM; VREYS I; YASUDA T; BUNTING S; GOLD HK
      ANTITHROMBOTIC EFFECTS AND BLEEDING-TIME PROLONGATION WITH SYNTHETIC PLATELET GPIIB IIIA INHIBITORS IN ANIMAL-MODELS OF PLATELET-MEDIATED THROMBOSIS/

      Thrombosis and haemostasis
    65. EISENBERG PR
      THROMBOSIS AND FIBRINOLYSIS IN ACUTE MYOCARDIAL-INFARCTION

      Alcoholism, clinical and experimental research
    66. VICKERS S; DUNCAN CA; YUAN AS; VYAS KP
      DISPOSITION OF MK-852, A FIBRINOGEN RECEPTOR ANTAGONIST, IN RATS AND DOGS

      Drug metabolism and disposition
    67. ELDRED CD; EVANS B; HINDLEY S; JUDKINS BD; KELLY HA; KITCHIN J; LUMLEY P; PORTER B; ROSS BC; SMITH KJ; TAYLOR NR; WHEATCROFT JR
      ORALLY-ACTIVE NONPEPTIDE FIBRINOGEN RECEPTOR (GPIIB IIIA) ANTAGONISTS- IDENTIFICATION OF NOMETHYL)PHENYL]-1-PIPERAZINYL]-1-PIPERIDINEACETIC ACID AS A LONG-ACTING, BROAD-SPECTRUM ANTITHROMBOTIC AGENT/

      Journal of medicinal chemistry
    68. YASUDA T; GOLD HK; KOHMURA C; GUERRERO L; YAOITA H; FALLON JT; BUNTING S; COLLEN D
      INTRAVENOUS AND ENDOBRONCHIAL ADMINISTRATION OF G4120, A CYCLIC ARG-GLY-ASP-CONTAINING PLATELET GPIIB IIIA RECEPTOR BLOCKING PENTAPEPTIDE, ENHANCES AND SUSTAINS CORONARY ARTERIAL THROMBOLYSIS WITH RT-PA IN A CANINE PREPARATION/

      Arteriosclerosis and thrombosis
    69. KOHMURA C; GOLD HK; YASUDA T; HOLT R; NEDELMAN MA; GUERRERO JL; WEISMAN HF; COLLEN D
      A CHIMERIC MURINE HUMAN ANTIBODY FAB FRAGMENT DIRECTED AGAINST THE PLATELET GPIIB/IIIA RECEPTOR ENHANCES AND SUSTAINS ARTERIAL THROMBOLYSISWITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN BABOONS/

      Arteriosclerosis and thrombosis
    70. TSCHOPP JF; DRISCOLL EM; MU DX; BLACK SC; PIERSCHBACHER MD; LUCCHESI BR
      INHIBITION OF CORONARY-ARTERY REOCCLUSION AFTER THROMBOLYSIS WITH AN RGD-CONTAINING PEPTIDE WITH NO SIGNIFICANT EFFECT ON BLEEDING-TIME

      Coronary artery disease


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/02/20 alle ore 18:07:35